Application Type
Patent
Application SubType
PCT National Phase
(10) Registration Number and Date
BNN20190052 07.01.2020
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
BN N/2019/0052 10.10.2017
(40) Publication Number and Date
BN N/2019/0052
A
07.01.2020
(86) PCT Filing Number and Date
(87) PCT Publication Number and Date
(85) National Entry Date
(30) Priority Details
US 62/554,817
06.09.2017
US 62/491,164
27.04.2017
US 62/406,252
10.10.2016
US 62/447,850
18.01.2017
US 62/566,093
29.09.2017
(74) Representative Name
(EN) AIP Law : Unit Nos. 404A-410A, 4th Floor, Wisma Jaya, Jalan Pemancha, Bandar Seri Begawan BS8811, Brunei Darussalam
(54) Title
(EN) SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
(57) Abstract
(EN)

Provided herein are compounds of the Formula I and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, X1, X2, X3, X4, Ring D, and E have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.

--
(58) Citations
Document Type Date Action
Event NameDateStatus
Filing10.10.2017Filed
PCT National Phase Entry10.04.2019PCT National Phase
Registration07.01.2020Registered
Publication07.01.2020Published